The prevalence of elevated CA15-3 increased with an increase in the TNM stage but did not reach statistical significance ( p >0.05; stages I 22.7%, II 31.2%, and III 42.6%).
← all excerpts
Elevated pre-surgical CA15-3: does it predict the short-term disease-free survival of breast cancer patients without distant metastasis?
1
0.0500
0.0500